Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-016-4983-4PMID 27000755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications

  2016cited by this paper
• Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E‐cadherin in renal cell carcinoma

  2016cited by this paper
• Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells

  2015cited by this paper
• MAP Kinase Cascades in Antigen Receptor Signaling and Physiology.

  2015cited by this paper
• Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis

  2013cited by this paper
• Retracted: Role of STAT3 and vitamin D receptor in EZH2‐mediated invasion of human colorectal cancer

  2013cited by this paper
• Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma.

  2013cited by this paper
• EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53.

  2013cited by this paper
• Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2

  2013cited by this paper
• Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.

  2013cited by this paper
• Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.

  2012cited by this paper
• EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer

  2012cited by this paper
• The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells

  2012cited by this paper
• Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

  2012cited by this paper
• Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia

  2012cited by this paper
• [A preliminary study on the relationship between EZH2 and microRNA-101 and the prognostic role of EZH2 in acute myeloid leukemia].

  2012cited by this paper
• Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring

  2011cited by this paper
• Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.

  2011cited by this paper
• The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.

  2010cited by this paper
• The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.

  2010cited by this paper
• Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

  2009cited by this paper
• CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

  2009cited by this paper
• Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia

  2008cited by this paper
• Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia

  2007cited by this paper
• Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells

  2006cited by this paper
• Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.

  2004cited by this paper
• Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

  2004cited by this paper
• Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome.

  2004cited by this paper
• Role of Histone H3 Lysine 27 Methylation in X Inactivation

  2003cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

  2001cited by this paper
• Disease Features in Acute Myeloid Leukemia with t(8;21)(q22;q22). Influence of Age, Secondary Karyotype Abnormalities, CD19 Status, and Extramedullar Leukemia on Survival

  2000cited by this paper
• Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells

  1999cited by this paper
• Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

  1997cited by this paper

• EZH2 Gene Expression and SOCS1 Gene Methylation in Acute Myeloid Leukemia: Unraveling Epigenetic Interactions and Clinical Implications

  2025cites this paper
• Azelaic acid attenuates CCL2/CCR2 axis-mediated skin trafficking of acute myeloid leukemia cells through NF-κB/MAPK signaling modulation in keratinocytes

  2025cites this paper
• Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients

  2023cites this paper
• Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology

  2023cites this paper
• Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

  2020cites this paper
• Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype

  2019cites this paper
• EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia

  2019cites this paper
• Roles of Polycomb gene EED in pathogenesis and prognosis of acute myeloid leukemia and diffuse large B cell lymphoma

  2018cites this paper
• Myeloid Sarcoma: The Other Side of Acute Leukemia

  2018cites this paper
• EZH2 Expression in Naturally Occurring Canine Tumors.

  2018cites this paper
• T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.

  2017cites this paper
• Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2

  2016cites this paper
• Short-Course High-Dose Methylprednisolone Induces Differentiation and Apoptosis of Myeloid Leukemic Cells

  2016influential citation